COLUMN GROUP III, LP — SEC insider filings

SEC reporting owner CIK 1668159. 50 insider filings on record with FilingPulse; latest filed 2026-10-22.

Transaction summary — filings shown

Covers all 50 filings on record, filed 2020-08-17 to 2026-10-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Revolution Medicines, Inc. (RVMD)10% owner1—2 legs · 2,027,156 sh · $73,788,478—
Tenaya Therapeutics, Inc. (TNYA)10% owner118 legs · 49,313,559 sh · $64,556,62012 legs · 9,400,290 sh · $5,927,19910
NGM BIOPHARMACEUTICALS INC (NGM)10% owner2772 legs · 3,899,822 sh · $31,317,626—14
Surrozen, Inc./DE (SRZN)10% owner925 legs · 1,838,785 sh · $23,984,607—35
CONSTELLATION PHARMACEUTICALS INC (CNST)10% owner2—1 leg · 10,000 sh · $369,5032

Insider filings — COLUMN GROUP III, LP

FiledFormIssuerReported transactionsSource
2026-10-224Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter
Option exercise/expiry (X): 485,830 @ $11.60 · Option exercise/expiry (X): 548,653 @ $11.60 · Option exercise/expiry (X): 517,241 @ $11.60 · Option exercise/expiry (X): 728,745 (derivative) · Option exercise/expiry (X): 822,980 (derivative) · Option exercise/expiry (X): 775,861 (derivative) · +3 moreEDGAR
2026-02-264Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter
Sale (S): 309,228 @ $0.62 · Sale (S): 349,212 @ $0.62 · Sale (S): 1,649,281 @ $0.56 · Sale (S): 1,862,545 @ $0.56EDGAR
2026-02-244Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter
Sale (S): 245,965 @ $0.61 · Sale (S): 277,769 @ $0.61 · Sale (S): 143,709 @ $0.60 · Sale (S): 162,291 @ $0.60EDGAR
2026-02-124Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter
Sale (S): 161,422 @ $0.82 · Sale (S): 182,295 @ $0.82 · Sale (S): 1,905,115 @ $0.68 · Sale (S): 2,151,458 @ $0.68EDGAR
2026-01-204Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter
Purchase (P): 5,590 @ $19.89 · Purchase (P): 6,303 @ $19.89 · Purchase (P): 1,204 @ $20 · Purchase (P): 1,358 @ $20 · Purchase (P): 8,484 @ $19.60 · Purchase (P): 9,568 @ $19.60EDGAR
2026-01-154Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter
Purchase (P): 5,861 @ $19.80 · Purchase (P): 6,609 @ $19.80 · Purchase (P): 2,596 @ $19.99 · Purchase (P): 2,927 @ $19.99EDGAR
2026-01-084Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter
Purchase (P): 7,097 @ $19.89 · Purchase (P): 8,003 @ $19.89EDGAR
2025-12-084Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 2,475 @ $17.35 · Purchase (P): 14,503 @ $19.54 · Purchase (P): 2,791 @ $17.35 · Purchase (P): 16,381 @ $19.54EDGAR
2025-11-174Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 148,150 @ $12.65 · Purchase (P): 167,307 @ $12.65EDGAR
2025-03-284Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 323,886 @ $11.60 · Purchase (P): 365,769 @ $11.60 · Purchase (P): 344,827 @ $11.60 · Code (H): 90,897 (derivative) · Purchase (P): 90,897 (derivative) · Code (H): 102,651 (derivative) · +15 moreEDGAR
2025-03-074Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 35,714,284 @ $0.70 · Purchase (P): 35,714,284 (derivative) · Purchase (P): 17,857,142 (derivative)EDGAR
2024-04-174/ASurrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP
Purchase (P): 90,897 @ $15.50 · Purchase (P): 102,651 @ $15.50EDGAR
2024-04-084NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Disposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · Disposition to issuer (D): 858,035 · Disposition to issuer (D): 968,990 · +8 moreEDGAR
2024-04-084Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP
Purchase (P): 90,897 @ $15.50 · Purchase (P): 102,651 @ $15.50 · Purchase (P): 90,897 (derivative) · Purchase (P): 102,651 (derivative) · Purchase (P): 98,870 (derivative) · Purchase (P): 111,656 (derivative) · +4 moreEDGAR
2024-02-144Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 2,222,222 @ $4.50EDGAR
2023-11-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 16,791 @ $0.71 · Purchase (P): 5,840 @ $0.62EDGAR
2023-03-144Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 6,779 @ $2.60EDGAR
2023-02-104Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 1,500,000 @ $2.60EDGAR
2023-02-014NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 7,542 @ $5.00 · Purchase (P): 176,730 @ $5.00EDGAR
2023-01-254NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 9,900 @ $5.00EDGAR
2023-01-234NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 37,639 @ $5.00 · Purchase (P): 500 @ $5.00EDGAR
2023-01-234Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 69,739 @ $2.50EDGAR
2023-01-194Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 49,463 @ $2.49 · Purchase (P): 135,688 @ $2.52EDGAR
2023-01-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 5,378 @ $4.95EDGAR
2023-01-124NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 100,070 @ $4.84 · Purchase (P): 209,000 @ $4.76EDGAR
2022-12-144NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 300 @ $4.98EDGAR
2022-11-234NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 35,997 @ $5.00 · Purchase (P): 4,330 @ $5.00EDGAR
2022-11-234Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 9,615,384 @ $2.60EDGAR
2022-11-074NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 104,090 @ $4.99 · Purchase (P): 35,058 @ $4.72EDGAR
2022-10-314NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 76,877 @ $4.86EDGAR
2022-10-274NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 51,046 @ $4.75 · Purchase (P): 72,774 @ $4.85EDGAR
2022-06-134NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 951,684 @ $13.50 · Purchase (P): 32,477 @ $13.50EDGAR
2022-06-064NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 33,071 @ $13.03 · Purchase (P): 1,129 @ $13.03EDGAR
2022-06-024NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 59,766 @ $13.47 · Purchase (P): 2,040 @ $13.47 · Purchase (P): 88,964 @ $13.45 · Purchase (P): 3,036 @ $13.45EDGAR
2022-05-314NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 19,534 @ $13.49 · Purchase (P): 667 @ $13.49 · Purchase (P): 2,621 @ $13.45 · Purchase (P): 89 @ $13.45EDGAR
2022-05-264NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 17,240 @ $13.37 · Purchase (P): 588 @ $13.37 · Purchase (P): 41,863 @ $13.43 · Purchase (P): 1,429 @ $13.43EDGAR
2022-05-234NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 19,984 @ $13.25 · Purchase (P): 682 @ $13.25 · Purchase (P): 18,406 @ $13.48 · Purchase (P): 628 @ $13.48EDGAR
2022-05-194NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 86,110 @ $13.42 · Purchase (P): 2,939 @ $13.42 · Purchase (P): 60,583 @ $13.20 · Purchase (P): 2,067 @ $13.20EDGAR
2022-05-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 125,096 · Purchase (P): 4,269 · Purchase (P): 32,072 @ $12.90 · Purchase (P): 1,094 @ $12.90EDGAR
2022-05-134NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 77,866 @ $11.23 · Purchase (P): 2,657 @ $11.23 · Purchase (P): 2,564 @ $11.85 · Purchase (P): 88 @ $11.85 · Purchase (P): 79,945 @ $11.62 · Purchase (P): 2,728 @ $11.62 · +2 moreEDGAR
2022-05-114NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 80,430 @ $10.79 · Purchase (P): 2,745 @ $10.79 · Purchase (P): 30,233 @ $11.36 · Purchase (P): 1,032 @ $11.36EDGAR
2022-01-264NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 241,750 · Purchase (P): 8,250 · Purchase (P): 579,910 · Purchase (P): 19,791EDGAR
2021-08-044Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP
Conversion (C): 4,389,282 @ $0 · Conversion (C): 4,956,842 @ $0 · Conversion (C): 3,727,742 (derivative) · Conversion (C): 4,209,755 (derivative) · Conversion (C): 472,659 (derivative) · Conversion (C): 533,781 (derivative) · +2 moreEDGAR
2021-02-194CONSTELLATION PHARMACEUTICALS INC (CNST)
jointly with COLUMN GROUP L P, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, COLUMN GROUP GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim
Sale (S): 10,000 @ $36.95EDGAR
2020-12-164CONSTELLATION PHARMACEUTICALS INC (CNST)
jointly with COLUMN GROUP L P, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, COLUMN GROUP GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim
Option exercise/expiry (X): 30,107 @ $1.55 · Option exercise/expiry (X): 30,107 (derivative) @ $0EDGAR
2020-11-184Revolution Medicines, Inc. (RVMD)
jointly with COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, PONOI CAPITAL, LP, Ponoi Capital II, LP, Ponoi Management, LLC, Ponoi II Management, LLC, Kutzkey Tim, GOEDDEL DAVID V
Sale (S): 952,023 @ $36.40 · Sale (S): 1,075,133 @ $36.40EDGAR
2020-09-034NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, Svennilson Peter, GOEDDEL DAVID V
Purchase (P): 36,494 @ $17.64 · Purchase (P): 27,595 @ $17.67EDGAR
2020-08-314NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, GOEDDEL DAVID V, Svennilson Peter
Purchase (P): 36,359 @ $17.79 · Purchase (P): 26,135 @ $17.89EDGAR
2020-08-254NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, GOEDDEL DAVID V, Svennilson Peter
Purchase (P): 7,321 @ $17.97 · Purchase (P): 11,024 @ $17.96 · Purchase (P): 100 @ $18EDGAR
2020-08-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, GOEDDEL DAVID V, Svennilson Peter
Purchase (P): 19,895 @ $17.89 · Purchase (P): 37,993 @ $17.49 · Purchase (P): 6,425 @ $17.89EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1668159 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs